Cytokinetics CEO Sells 11,500 Shares
| Reporter Name | Blum Robert I |
| Relationship | President & CEO |
| Type | Sell |
| Amount | $624,335 |
| SEC Filing | Form 4 |
On July 10, 2024, Robert I Blum, President & CEO of Cytokinetics, sold 11,500 shares of common stock at a price of $54.29 per share, totaling $624,335. Following the transaction, Blum directly owns 399,412 shares and indirectly owns 4,166 shares through trusts.
SEC Filing: CYTOKINETICS INC [ CYTK ] - Form 4 - Jul. 10, 2024